03:01:46 EST Sat 07 Feb 2026
Enter Symbol
or Name
USA
CA



Q:CERS - CERUS CORP - https://www.cerus.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CERS - Q0.61.94·2.500.12.20+0.062.81,263.62,5994,2522.20  2.26  2.1122.955  1.1219:12:30Jan 2215 min RT 2¢

Recent Trades - Last 10 of 4252
Time ETExPriceChangeVolume
19:12:30Q2.200.062
16:10:04Q2.200.061
16:10:04Q2.200.061
16:10:04Q2.200.061
16:04:35Q2.200.061
16:04:29Q2.200.061
16:04:23Q2.200.061
16:04:22Q2.200.061
16:04:14Q2.13-0.011
16:04:12Q2.200.061

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-01-22 07:30U:CERSNews ReleaseDRK Blood Donation Service Baden-Wurttemberg - Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus' INTERCEPT(TM) Blood System in Routine Clinical Practice
2026-01-11 16:00U:CERSNews ReleaseCerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook
2025-12-10 16:15U:CERSNews ReleaseCerus Corporation Announces Group Purchasing Agreement with Blood Centers of America
2025-11-06 16:01U:CERSNews ReleaseCerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance
2025-10-21 08:30U:CERSNews ReleaseCerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting
2025-10-16 16:00U:CERSNews ReleaseCerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025
2025-08-25 09:00U:CERSNews ReleaseThe German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions
2025-08-21 08:30U:CERSNews ReleaseCerus Corporation to Participate in the Cantor Global Healthcare Conference 2025
2025-08-05 16:01U:CERSNews ReleaseCerus Corporation Announces Second Quarter 2025 Financial Results
2025-07-22 16:15U:CERSNews ReleaseCerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025
2025-07-21 08:30U:CERSNews ReleaseCerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury
2025-07-02 08:30U:CERSNews ReleaseCerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update
2025-06-13 16:01U:CERSNews ReleaseCerus Corporation Celebrates World Blood Donor Day 2025
2025-06-03 16:30U:CERSNews ReleaseCerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025
2025-05-29 08:30U:CERSNews ReleaseCerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan
2025-05-28 08:30U:CERSNews ReleaseCerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 - Next-Generation INTERCEPT Illumination Device
2025-05-01 16:00U:CERSNews ReleaseCerus Corporation Announces First Quarter 2025 Financial Results
2025-04-17 08:30U:CERSNews ReleaseCerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025
2025-03-05 13:00U:CERSNews ReleaseCerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200)
2025-02-20 16:00U:CERSNews ReleaseCerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results